C
Cytomx Therapeutics (CTMX)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Cytomx Therapeutics (CTMX)
CytomX Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company. The Company uses its Probody technology platform to create cancer immunotherapies against clinically validated targets, as well as to develop cancer therapeuti... Read more
- USD0.97
- USD1.04
- USD0.90
- USD4.49
- 111.00%
- 138M
- 2.55M
- 1.46M
- 65M
- 0.40
- -78.30%
- 6.90%
Stock News
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
